Dermata receives Australian patent acceptance for acne treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. BAC
5. SPY
6. WFC
7. ERAS
8. SPRO
9. TSCO
10. AAPL

Go back to Dermata receives Australian patent acceptance for acne treatment
(NASDAQ: DRMA) Delayed: 1.35 --0 (-0%)
Previous Close $1.35    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $1.35    P/E N/A 
Day Low $1.35    EPS $ 
Volume 177       

(NASDAQ: DRMAW) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $ 
Volume 52,624